Do you have an idea brave enough to end coronary heart disease?

Submissions

One Team. One Vision. One Cure.

Through a $75 million investment over at least five years, the American Heart Association and Verily, with support from AstraZeneca, are embarking on a groundbreaking research enterprise focused on preventing or reversing coronary heart disease and, ultimately, improving and restoring cardiovascular health. This marks the start of a bold and new chapter as the largest one-time investment in a team with a focus to end coronary heart disease.

American Heart Association Verily AstraZeneca
$75 MILLION + substantial resources and support from all three.
Learn More

See what people are Saying